HIMS vs DOCS
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
HIMS · Hims & Hers Health$14.60 ▼ 8.86%
DOCS · Doximity$28.73 ▼ 2.97%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- HIMS -61.4%
- DOCS -42.5%
Head to head
| Metric | HIMS | DOCS |
|---|---|---|
| Price | $14.60 | $28.73 |
| Change today | ▼ 8.86% | ▼ 2.97% |
| Market cap | $3.42B | $5.13B |
| Return, 3 months | -53.0% | +13.6% |
| Return, year to date | -55.0% | -35.1% |
| Return, 1 year | -57.9% | -43.0% |
| P/E (TTM) | – | 39.9 |
| P/B | 9.6 | 5.5 |
| P/E percentile vs own 5y | 39th | 47th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | +48.6% | +3.6% |
| Net profit growth (YoY) | -309.5% | -44.0% |
| Gross margin | 63.8% | 86.8% |
| Operating margin | -8.1% | 26.3% |
| Net margin | -6.7% | 21.1% |
| Return on equity | -40.8% | 13.8% |
| Analyst target vs. price | +100.1% | +4.0% |
| Analyst buy share | 25% | 40% |
| RSI (14) | 25 | 35 |
| 30-day volatility | 97.5% | 43.3% |
| Max drawdown, 1 year | -64.6% | -65.8% |
| Trend read | Strong downtrend | Leaning bearish |
| Analyst consensus | Buy | Hold |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- DOCS is the largest of the group by market value.
- DOCS has returned the most over the past year.
- HIMS is growing revenue fastest.
- DOCS keeps the most profit per dollar of sales.
- DOCS has been the calmest stock over the last 30 days.